TG003

CAS No. 300801-52-9

TG003( —— )

Catalog No. M13931 CAS No. 300801-52-9

TG003 is a potent and ATP-competitive Cdc2-like kinase (Clk) inhibitor with IC50 of 20 nM, 200 nM, and 15 nM for Clk1, Clk2, and Clk4, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 52 In Stock
5MG 73 In Stock
10MG 126 In Stock
25MG 251 In Stock
50MG 429 In Stock
100MG 628 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TG003
  • Note
    Research use only, not for human use.
  • Brief Description
    TG003 is a potent and ATP-competitive Cdc2-like kinase (Clk) inhibitor with IC50 of 20 nM, 200 nM, and 15 nM for Clk1, Clk2, and Clk4, respectively.
  • Description
    TG003 is a potent and ATP-competitive Cdc2-like kinase (Clk) inhibitor with IC50 of 20 nM, 200 nM, and 15 nM for Clk1, Clk2, and Clk4, respectively. No inhibitory effect on Clk3, SRPK1, SRPK2, or PKC.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    Bcl-2
  • Recptor
    mCLK1| mCLK2| mCLK4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    300801-52-9
  • Formula Weight
    249.33
  • Molecular Formula
    C13H15NO2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 6 mg/mL warmed (24.06 mM)
  • SMILES
    CCN\1C2=C(C=CC(=C2)OC)S/C1=C\C(=O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Muraki M, et al. J Biol Chem. 2004, 279(23), 24246-24254.
molnova catalog
related products
  • BAI1

    BAI1 (Bax channel blocker) is a potent inhibitor of Bax-mediated mitochondrial cytochrome C release (IC50: 0.52 μM).

  • BI-5273

    A negative control compound of BI-3802 and BI-3812, which are potent and efficacious BCL6 degrader and inhibitor, respectively.

  • ML311

    ML311 is a selective inhibitor of the Mcl-1/Bim interaction.